Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies

doi:10.3748/wjg.v25.i6.659

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (14333)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

990

WORD

397

HTML

9032

Figures (1-3)

387

Sum=10806

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

615

Download

641

Sum=1256

Publishing Process of This Article

Item

Count

Browse

1036

Download

1235

Sum=2271

Feb 14, 2019 (publication date) through Dec 27, 2024

Times Cited of This Article

Times Cited (81)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Feb 14, 2019; 25(6): 659-671
Published online Feb 14, 2019. doi: 10.3748/wjg.v25.i6.659

Full Size Figure Download Figure

Figure 3 Suggested cholangiocarcinoma surveillance in patients with primary sclerosing cholangitis. Adapted from Tabibian et al[103], with permission. Red arrows represent assumes stable findings; CA 19-9: Carbohydrate antigen 19-9; CCA: Cholangiocarcinoma; ERC: Endoscopic retrograde cholangiography; GB: Gallbladder; GBC: Gallbladder cancer; FISH: Fluorescence in situ hybridization; HCC: Hepatocellular carcinoma; MRCP: Magnetic resonance cholangiopancreatography; US: Ultrasound; ERCP: Endoscopic retrograde cholangiopancreatography; MRI: Magnetic resonance imaging.

Citation: Fung BM, Lindor KD, Tabibian JH. Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies. World J Gastroenterol 2019; 25(6): 659-671
URL: https://www.wjgnet.com/1007-9327/full/v25/i6/659.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i6.659